Epidemiology of measles in Blantyre, Malawi: Analyses of passive surveillance data from 1996 to 1998

Epidemiology and Infection

Volumn 129, Issue 2, 2002, Pages 361-369

  Yamaguchi, S ^a,c   Dunga, A ^b   Broadhead, R L ^b   Brabin, B J ^c,d  

^a University of Ghana   (Ghana)

^b UNIVERSITY OF MALAWI   (Malawi)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; COUGHING; DIARRHEA; DRUG EFFICACY; FEMALE; HEALTH SURVEY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALAWI; MALE; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; PNEUMONIA; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALAWI; MALE; MEASLES; MEASLES VACCINE; MEDICAL RECORDS; OUTCOME ASSESSMENT (HEALTH CARE); PNEUMONIA, VIRAL; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEASONS; URBAN HEALTH;

EID: 0036773395     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268802007458     Document Type: Article

References (24)

1. WHO Expanded Programme on Immunization. Measles progress towards global control and regional elimination, 1990-1998. Wkly Epidemiol Rec 1998; 73: 389-94.
2. Slutsker L, Bloland P, Steketee RW, Wirima JJ, Heymann DL, Breman JG. Infant and second-year mortality in rural Malawi: causes and descriptive epidemiology. Am J Trop Med Hyg 1996; 55 (Suppl 1): 77-81.
3. WHO Expanded Programme on Immunization. Progress towards measles elimination, southern Africa, 1996-1998. Wkly Epidemiol Rec 1999; 74: 229-33.
4. Kaninda AV, Legros D, Jataou IM, et al. Measles vaccine effectiveness in standard and early immunization strategies, Niger, 1995. Pediatr Infect Dis J 1998; 17: 1034-9.
5. Porter JD, Gastellu-Etchegorry M, Navarre I, Lungu G, Moren A. Measles outbreaks in the Mozambican refugee camps in Malawi: the continued need for an effective vaccine. Int J Epidemiol 1990; 19: 1072-7.
6. Malawi Government, Ministry of Health and Population, National Immunization Days Secretariat. Malawi polio immunization campaign, 1997.
7. Malawi Government, National Statistical Office. Population and Housing Census: Report of Preliminary Results, 1998.
8. WHO Expanded Programme on Immunization. Using surveillance data and outbreak investigations to strengthen measles immunization programmes. WHO/EPI/GEN/96.02, 1996.
9. Aaby P, Andersen M, Knudsen K. Excess mortality after early exposure to measles. Int J Epidemiol 1993; 22: 156-62.
10. Edwards JH. The recognition and estimation of cyclic trends. Ann Hum Genet 1961; 25: 83-7.
11. Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Epidemiol Rev 1988; 10: 212-41.
12. Malawi Government, National Statistical Office. Malawi Knowledge, Attitudes and Practices Health Survey, 1996.
13. Farrington CP. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 1993; 22: 742-6.
14. Cutts FT, Henderson RH, Clements CJ, Chen RT, Patriarca PA. Principles of measles control. Bull WHO 1991; 69: 1-7.
15. Aaby P, Bukh J, Leerhoy J, Lisse IM, Mordhorst CH, Pedersen IR. Vaccinated children get milder measles infection: a community study from Guinea-Bissau. J Infect Dis 1986; 154: 858-63.
16. Fine PE, Clarkson JA. Measles in England and Wales - I: an analysis of factors underlying seasonal patterns. Int J Epidemiol 1982; 11: 5-14.
17. de Francisco A, Hall AJ, Unicomb L, Chakraborty J, Yunus M, Sack RB. Maternal measles antibody decay in rural Bangladeshi infants - implications for vaccination schedules. Vaccine 1998; 16: 564-8.
18. de Moraes-Pinto MI, Verhoeff F, Chimsuku L, et al. Placental antibody transfer: influence of maternal HIV infection and placental malaria. Arch Dis Child Fetal Neonatal Ed 1998; 79: F202-5.
19. Nkrumah FK, Osei-Kwasi M, Dunyo SK, Koram KA, Afari EA. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana. Bull WHO 1998; 76: 353-9.
20. Palumbo P, Hoyt L, Demasio K, Oleske J, Connor E. Population-based study of measles and measles immunization in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1992; 11: 1008-14.
21. Brabin L, Verhoeff FH, Kazembe P, Brabin BJ, Chimsuku L, Broadhead R. Improving antenatal care for pregnant adolescents in southern Malawi. Acta Obstet Gynecol Scand 1998; 77: 402-9.
22. Leopardi R, Hyypia T, Vainionpaa R. Effect of interferon-alpha on measles virus replication in human peripheral blood mononuclear cells. Apmis 1992; 100: 125-31.
23. Reyes MA, de Borrero MF, Roa J, Bergonzoli G, Saravia NG. Measles vaccine failure after documented seroconversion. Pediatr Infect Dis J 1987; 6: 848-51.
24. Wong RD, Goetz MB. Clinical and laboratory features of measles in hospitalized adults. Am J Med 1993; 95: 377-83.